"Interferon Type I" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA).
Descriptor ID |
D007370
|
MeSH Number(s) |
D12.644.276.374.440.890 D12.776.467.374.440.890 D23.529.374.440.890
|
Concept/Terms |
Interferon Type I- Interferon Type I
- Type I Interferons
- Interferons, Type I
- Interferons Type I
- Type I Interferon
- Interferon, Type I
|
Below are MeSH descriptors whose meaning is more general than "Interferon Type I".
Below are MeSH descriptors whose meaning is more specific than "Interferon Type I".
This graph shows the total number of publications written about "Interferon Type I" by people in this website by year, and whether "Interferon Type I" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 0 | 1 |
2002 | 0 | 1 | 1 |
2005 | 1 | 0 | 1 |
2006 | 0 | 2 | 2 |
2007 | 1 | 0 | 1 |
2008 | 1 | 1 | 2 |
2010 | 1 | 0 | 1 |
2011 | 1 | 1 | 2 |
2013 | 1 | 0 | 1 |
2014 | 0 | 2 | 2 |
2015 | 0 | 1 | 1 |
2016 | 0 | 2 | 2 |
2020 | 1 | 0 | 1 |
2022 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interferon Type I" by people in Profiles.
-
COVID-19 is associated with bystander polyclonal autoreactive B cell activation as reflected by a broad autoantibody production, but none is linked to disease severity. J Med Virol. 2023 01; 95(1):e28134.
-
COVID-19 mRNA vaccine BNT162b2 induces autoantibodies against type I interferons in a healthy woman. J Autoimmun. 2022 10; 132:102896.
-
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases. J Clin Invest. 2020 04 01; 130(4):1669-1682.
-
Plasmacytoid dendritic cell distribution and maturation are altered in lupus prone mice prior to the onset of clinical disease. Clin Immunol. 2017 02; 175:109-114.
-
Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus. Lupus. 2017 Jan; 26(1):62-72.
-
Estrogen Receptor a Deficiency Modulates TLR Ligand-Mediated PDC-TREM Expression in Plasmacytoid Dendritic Cells in Lupus-Prone Mice. J Immunol. 2015 Dec 15; 195(12):5561-71.
-
Advances in lupus genetics and epigenetics. Curr Opin Rheumatol. 2014 Sep; 26(5):482-92.
-
Plasmacytoid dendritic cells mediate synergistic effects of HIV and lipopolysaccharide on CD27+ IgD- memory B cell apoptosis. J Virol. 2014 Oct; 88(19):11430-41.
-
Cytokine synergy: an underappreciated contributor to innate anti-viral immunity. Cytokine. 2013 Sep; 63(3):237-40.
-
Anti-tumorigenic effects of Type 1 interferon are subdued by integrated stress responses. Oncogene. 2013 Sep 05; 32(36):4214-21.